Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, April 14, 2022
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
Matthew Sheerin Upgraded (CDW) to Strong Buy and Increased Target to $210 on, Apr 14th, 2022
Matthew Sheerin of Stifel, Upgraded "CDW Corporation" (CDW) to Strong Buy and Increased Target from $200 to $210 on, Apr 14th, 2022.
Matthew has made no other calls on CDW in the last 4 months.
There are 3 other peers that have a rating on CDW. Out of the 3 peers that are also analyzing CDW, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Katy Huberty of "Morgan Stanley" Maintained at Hold with Increased Target to $201 on, Thursday, February 10th, 2022
These are the ratings of the 2 analyists that currently disagree with Matthew
- Erik Woodring of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $214 on, Thursday, March 31st, 2022
- Adam Tindle of "Raymond James" Maintained at Buy with Increased Target to $220 on, Wednesday, February 2nd, 2022
